CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The TIMCC project focuses on understanding the role of tumor-infiltrating myeloid cells in cancer development and therapy. By analyzing these immune cells in human tumors and genetically modified mice, the project aims to identify molecular pathways that can enhance anti-tumor treatments.
The ITN TIMCC brings together eight expert teams from different disciplines within Immunology, Genetics and Oncology, to provide substantive and methodological training in the analysis of the role of the Tumor Infiltrating Myeloid Cell Compartment (TIMCC) of the innate immune system.
Leukocytes recruited to (pre)malignant tissues are mainly myeloid cells.
They can either prevent or functionally contribute to cancer development.
However, the mechanisms underlying pro- versus anti-tumor programmin…
Leiden University Medical Center
ACADEMISCH ZIEKENHUIS LEIDEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
Germany, Bonn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Uppsala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
